
|Videos|January 20, 2022
How appropriate use criteria was created for PSMA-PET imaging
Author(s)Urology Times staff
“There is a rather extensive process of how to develop appropriate use criteria. It is primarily based on literature and evidence, systematic reviews, and analysis of those data,” says Hossein Jadvar, MD, PhD.
Advertisement
In this video, Hossein Jadvar, MD, PhD, discusses the process for creating the appropriate use criteria for prostate-specific membrane antigen (PSMA) PET imaging that was recently released in the
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
High PHI scores are linked to increased odds of significant prostate cancer
2
Trial to evaluate novel combination in BCG-unresponsive NMIBC
3
Dosing begins in trial of alpha radioligand therapy for mCRPC
4
FDA grants fast track designation to Enolen for localized prostate cancer
5


















